Emaan Rana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emaan Rana has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Heshwin Singh
Departments of Neurosurgery, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York
1 shared publication - Magda Wojtara
Department of Research and Education, Oli Health Magazine Organization, Research, and Education, Kigali, Rwanda
1 shared publication - Palak Khanna
Department of Medicine Ivane Javakhishvili Tbilisi State University Tbilisi Georgia
1 shared publication - Taibia Rahman
David Tvildiani Medical University, Tbilisi, Georgia
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 30 August 2023
- Published by Wiley in Clinical and Translational Science
- Vol. 16 (11) , 2106-2111
Artificial intelligence in rare disease diagnosis and treatment
Artificial intelligence (AI) utilization in health care has grown over the past few years. It also has demonstrated potential in improving the efficiency of diagnosis and treatment. Some types of AI, such as machine learning, allow for the efficient analysis of vast datasets, identifying patterns, and generating key insights. Predictions can then be made for medical diagnosis and personalized treatment recommendations. The use of AI can bypass some conventional limitations associated with rare diseases. Namely, it can optimize traditional randomized control trials, and may eventually reduce costs for drug research and development. Recent advancements have enabled researchers to train models based on large datasets and then fine‐tune these models on smaller datasets typically associated with rare diseases. In this mini‐review, we discuss recent advancements in AI and how AI can be applied to streamline rare disease diagnosis and optimize treatment.
- 30 August 2023
- Published by Wiley in Clinical and Translational Science
- Vol. 16 (11) , 2106-2111
Top Cited PapersOpen AccessArtificial intelligence in rare disease diagnosis and treatment
Artificial intelligence (AI) utilization in health care has grown over the past few years. It also has demonstrated potential in improving the efficiency of diagnosis and treatment. Some types of AI, such as machine learning, allow for the efficient analysis of vast datasets, identifying patterns, and generating key insights. Predictions can then be made for medical diagnosis and personalized treatment recommendations. The use of AI can bypass some conventional limitations associated with rare diseases. Namely, it can optimize traditional randomized control trials, and may eventually reduce costs for drug research and development. Recent advancements have enabled researchers to train models based on large datasets and then fine‐tune these models on smaller datasets typically associated with rare diseases. In this mini‐review, we discuss recent advancements in AI and how AI can be applied to streamline rare disease diagnosis and optimize treatment.